Real-World Treatment Patterns and Outcomes from an Electronic Medical Records Database for Patients with Rheumatoid Arthritis Treated with Repository Corticotropin Injection

References

• Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–2038. doi:10.1016/S0140-6736(16)30173-8
   PubMed Web of Science ®Google Scholar
• Strand V, Tundia N, Song Y, Macaulay D, Fuldeore M. Economic burden of patients with inadequate response to targeted immunomodulators for rheumatoid arthritis. J Manag Care Spec Pharm. 2018;24(4):344–352. doi:10.18553/jmcp.2018.24.4.344
   PubMed Web of Science ®Google Scholar
• Markusse IM, Dirven L, Gerards AH, et al. Disease flares in rheumatoid arthritis are associated with joint damage progression and disability: 10-year results from the BeSt study. Arthritis Res Ther. 2015;17(1):232. doi:10.1186/s13075-015-0730-2
   PubMed Web of Science ®Google Scholar
• Singh JA, Saag KG, Bridges SL Jr, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2016;68(1):1–25. doi:10.1002/acr.22783
   PubMed Web of Science ®Google Scholar
• Kuijper TM, Lamers-Karnebeek FB, Jacobs JW, Hazes JM, Luime JJ. Flare rate in patients with rheumatoid arthritis in low disease activity or remission when tapering or stopping synthetic or biologic DMARD: a systematic review. J Rheumatol. 2015;42(11):2012–2022. doi:10.3899/jrheum.141520
   PubMed Web of Science ®Google Scholar
• Mallinckrodt AR. HP Acthar Gel (Repository Corticotropin Injection). Mallinckrodt ARD; 2021.
   Google Scholar
• Huang YJ, Galen K, Zweifel B, Brooks LR, Wright AD. Distinct binding and signaling activity of Acthar Gel compared to other melanocortin receptor agonists. J Recept Signal Transduct Res. 2020;1–9. doi:10.1080/10799893.2020.1818094
   Web of Science ®Google Scholar
• Wang X, Pham L, Poola N, Brooks LR, Due B. Comparison of steroidogenic exposure following the administration of repository corticotropin injection with a synthetic ACTH1-24 depot and methylprednisolone in healthy subjects. Clin Pharmacol Drug Dev. 2020. doi:10.1002/cpdd.894
   Web of Science ®Google Scholar
• Catania A, Lonati C, Sordi A, Carlin A, Leonardi P, Gatti S. The melanocortin system in control of inflammation. ScientificWorldJournal. 2010;10:1840–1853. doi:10.1100/tsw.2010.173
   PubMed Web of Science ®Google Scholar
• Catania A, Gatti S, Colombo G, Lipton JM. Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol Rev. 2004;56(1):1–29. doi:10.1124/pr.56.1.1
   PubMed Web of Science ®Google Scholar
• Ahmed TJ, Montero-Melendez T, Perretti M, Pitzalis C. Curbing inflammation through endogenous pathways: focus on melanocortin peptides. Int J Inflam. 2013;2013:985815. doi:10.1155/2013/985815
   PubMedGoogle Scholar
• Olsen NJ, Decker DA, Higgins P, et al. Direct effects of HP Acthar Gel on human B lymphocyte activation in vitro. Arthritis Res Ther. 2015;17(1):300. doi:10.1186/s13075-015-0823-y
   Web of Science ®Google Scholar
• Healy LMJJ, Lin YH, Rao V, Antel JP, Wright D. ePosters. Mult Scler. 2017;23(3_suppl):680–975. doi:10.1177/1352458517731285
   Google Scholar
• Wright D, Sharma P, Galen K, Fitch R. AB0082 reduced steroidogenic activity of repository corticotropin injection (RCI) induces a distinct cytokine response following T cell activation in vivo. Ann Rheum Dis. 2019;78:1504.
   Web of Science ®Google Scholar
• Hayes K, Panaccio MP, Goel N, Fahim M. Patient characteristics and indicators of treatment initiation with repository corticotropin injection in patients with rheumatoid arthritis: a claims database analysis. Rheumatol Ther. 2021;8(1):327–346. doi:10.1007/s40744-020-00272-x
   Web of Science ®Google Scholar
• Fischer PA, Rapoport RJ. Repository corticotropin injection in patients with rheumatoid arthritis resistant to biologic therapies. Open Access Rheumatol. 2018;10:13–19. doi:10.2147/OARRR.S153307
   Web of Science ®Google Scholar
• Fleischmann R, Furst DE, Connolly-Strong E, Liu J, Zhu J, Brasington R. Repository corticotropin injection for active rheumatoid arthritis despite aggressive treatment: a randomized controlled withdrawal trial. Rheumatol Ther. 2020;7(2):327–344. doi:10.1007/s40744-020-00199-3
   PubMed Web of Science ®Google Scholar
• Fleischmann R, Furst DE. Safety of repository corticotropin injection as an adjunctive therapy for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2020;19(8):935–944. doi:10.1080/14740338.2020.1779219
   PubMed Web of Science ®Google Scholar
• Philbin M, Niewoehner J, Wan GJ. Clinical and economic evaluation of repository corticotropin injection: a narrative literature review of treatment efficacy and healthcare resource utilization for seven key indications. Adv Ther. 2017;34(8):1775–1790. doi:10.1007/s12325-017-0569-9
   PubMed Web of Science ®Google Scholar
• Gillis T, Crane M, Hinkle C, Wei N. Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action. Open Access Rheumatol. 2017;9:131–138. doi:10.2147/OARRR.S131046
   PubMed Web of Science ®Google Scholar
• Aletaha D, Smolen J. The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol. 2005;23(5 Suppl 39):S100–8.
   PubMed Web of Science ®Google Scholar
• Rheumatology. Routine Assessment of Patient Index Data. [survey] Available from: https://www.rheumatology.org/Portals/0/Files/RAPID3%20Form.pdf. Accessed May 20, 2021.
   Google Scholar
• Kumar BS, Suneetha P, Mohan A, Kumar DP, Sarma KVS. Comparison of disease activity score in 28 joints with ESR (DAS28), Clinical Disease Activity Index (CDAI), Health Assessment Questionnaire Disability Index (HAQ-DI) & Routine Assessment of Patient Index Data with 3 measures (RAPID3) for assessing disease activity in patients with rheumatoid arthritis at initial presentation. Indian J Med Res. 2017;146(Supplement):S57–S62. doi:10.4103/ijmr.IJMR_701_15
   PubMed Web of Science ®Google Scholar
• Pincus T, Swearingen CJ, Bergman M, Yazici Y. RAPID3 (Routine Assessment of Patient Index Data 3), a rheumatoid arthritis index without formal joint counts for routine care: proposed severity categories compared to disease activity score and clinical disease activity index categories. J Rheumatol. 2008;35(11):2136–2147. doi:10.3899/jrheum.080182
   PubMed Web of Science ®Google Scholar
• Ward MM, Castrejon I, Bergman MJ, Alba MI, Guthrie LC, Pincus T. Minimal clinically important improvement of routine assessment of patient index data 3 in rheumatoid arthritis. J Rheumatol. 2019;46(1):27–30. doi:10.3899/jrheum.180153
   Web of Science ®Google Scholar
• Wolfe F, Michaud K. Assessment of pain in rheumatoid arthritis: minimal clinically significant difference, predictors, and the effect of anti-tumor necrosis factor therapy. J Rheumatol. 2007;34(8):1674–1683.
   Web of Science ®Google Scholar
• Lee DM, Weinblatt ME. Rheumatoid arthritis. Lancet. 2001;358(9285):903–911. doi:10.1016/S0140-6736(01)06075-5
   PubMed Web of Science ®Google Scholar
• Feng X, Xu X, Shi Y, et al. Body mass index and the risk of rheumatoid arthritis: an updated dose-response meta-analysis. Biomed Res Int. 2019;2019:3579081. doi:10.1155/2019/3579081
   PubMed Web of Science ®Google Scholar
• Ho-Mahler N, Turner B, Eaddy M, Hanke ML, Nelson WW. Treatment with repository corticotropin injection in patients with rheumatoid arthritis, systemic lupus erythematosus, and dermatomyositis/polymyositis. Open Access Rheumatol. 2020;12:21–28. doi:10.2147/OARRR.S231667
   PubMed Web of Science ®Google Scholar
• Busch H, Wan GJ, Niewoehner J, Houston P, Su Y, Panccio MP. Real-world treatment patterns for repository corticotropin injection in patients with rheumatoid arthritis. Rheumatol Ther. 2021; submitted.
   Web of Science ®Google Scholar
• Hammer HB, Michelsen B, Provan SA, et al. Tender joint count and inflammatory activity in patients with established rheumatoid arthritis: results from a longitudinal study. Arthritis Care Res. 2020;72(1):27–35. doi:10.1002/acr.23815
   Web of Science ®Google Scholar
• Chopra I, Qin Y, Kranyak J, et al. Repository corticotropin injection in patients with advanced symptomatic sarcoidosis: retrospective analysis of medical records. Ther Adv Respir Dis. 2019;13:1753466619888127. doi:10.1177/1753466619888127
   Web of Science ®Google Scholar
• Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol. 2021;73(7):1108–1123. doi:10.1002/art.41752
   PubMed Web of Science ®Google Scholar
• Gliklich RE, Leavy MB, Dreyer NA, eds. Registries for Evaluating Patient Outcomes: A User’s Guide. 4th ed. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020.
   Google Scholar